Apr. 30, 2025 — Semaglutide effectively treats liver ... 2025 — A comprehensive study shows that people with fatty liver disease have almost twice the mortality rate of the general population.

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...

which involved around 800 patients treated with semaglutide or placebo on top of standard care and followed for 72 weeks. MASH is a form of non-alcoholic fatty liver disease (NAFLD) that affects ...

For example, liraglutide and semaglutide. For example ... relevant to the scope of this Seminar with the terms “non-alcoholic fatty liver disease”, “non-alcoholic steatohepatitis”, “NAFLD”, “NASH”, ...

In recent years, a certain type of medication has seen increased popularity due to its purported health effects. But taking ...

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows ...

Drug-induced liver injury cases are increasing, with common medications and supplements posing hidden dangers, especially for ...

Any thoughts on milk thistle supplements in fatty liver disease that was diagnosed by an ultrasound due to elevated AST and ...

Improves fibrosis and steatohepatitis Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad clinical spectrum, ranging from simple steatosis to metabolic ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...